Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2025
Business Overview: Herbalife is a global nutrition company selling weight management, targeted nutrition, energy, sports, fitness, and outer nutrition products through a network of independent members. Operations are organized into five geographic regions: North America, Latin America, EMEA, Asia Pacific, and China.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Sales | $1,221.7 | $1,264.3 |
| Gross Profit | $956.5 | $979.3 |
| Gross Margin | 78.3% | 77.5% |
| Operating Income | $122.8 | $71.9 |
| Net Income | $50.4 | $24.3 |
| Diluted EPS | $0.49 | $0.24 |
| Operating Cash Flow | $0.2 | $13.8 |
| Cash and Cash Equivalents | $329.4 | $415.3 |
| Total Debt (Carrying Value) | $2,193.7 | $2,260.1 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3.4% year-over-year to $1,221.7 million. This was driven by a 4.8% unfavorable impact from foreign currency fluctuations and a 2.3% decrease in sales volume, partially offset by a 3.7% favorable impact from price increases. In local currency, net sales increased 1.4%.
- Profitability Surge: Net income increased 107.4% to $50.4 million. This significant improvement was primarily due to a $60.3 million reduction in Selling, General, and Administrative (SG&A) expenses (driven by lower labor/benefits and reduced restructuring costs) and a $13.4 million decrease in royalty overrides.
- Expense Reduction: SG&A expenses dropped to $431.9 million (35.3% of sales) from $492.2 million (38.9% of sales). Restructuring expenses were $3.3 million in Q1 2025 compared to $16.7 million in Q1 2024.
- Interest Expense: Net interest expense increased to $52.0 million from $37.9 million due to higher weighted-average interest rates following the April 2024 debt refinancing.
- Regional Performance:
- China: Sales declined 13.8% due to a 13.9% volume decrease.
- Latin America: Sales declined 3.5% in USD but increased 10.6% in local currency, driven by volume growth offset by currency headwinds.
- North America: Sales declined 4.3% due to an 8.0% volume decrease.
Guidance, Outlook, and Risks
- Capital Expenditures: The company expects full-year 2025 capital expenditures to range between $90 million and $120 million, including investments in the "Herbalife One" digital technology platform.
- Restructuring Outlook: The "Restructuring Program" is substantially complete, with expected annual savings of at least $80 million beginning in 2025. A new "Technology Realignment Program" was initiated in April 2025 with expected first-phase expenses of approximately $5 million.
- Debt Maturity: The company has $197.3 million of Senior Notes due in September 2025. Management expects sufficient resources to meet this obligation.
- Key Risks:
- Tax Contingencies: Significant ongoing tax assessments in Brazil (ICMS/ICMS-ST), Mexico (VAT), and India. The company has not accrued losses for these as they do not believe a loss is probable, but outcomes remain uncertain.
- Geopolitical & Economic: Exposure to inflation, foreign exchange fluctuations, and geopolitical conflicts (e.g., Ukraine, Middle East) impacting costs and sales volumes.
- Regulatory: Compliance with the FTC Consent Order and evolving direct-selling regulations in markets like Vietnam and China.
Investor Verification Checklist
- Cash Flow Quality: Verify the sustainability of operating cash flow, which dropped to $0.2 million in Q1 2025 compared to $13.8 million in Q1 2024, largely due to working capital changes (increases in receivables and inventory).
- Debt Service Capacity: Confirm the company's ability to repay the $197.3 million Senior Notes maturing in September 2025 given the current cash balance of $329.4 million and revolver availability.
- Tax Exposure: Monitor the resolution of tax assessments in Brazil and India, which could result in significant non-cash or cash outflows if the company's "not probable" assessment changes.
- China Volume Trends: Assess whether the 13.9% volume decline in China stabilizes, as this region represents a distinct reporting segment with unique regulatory challenges.
- Restructuring Savings: Track the realization of the projected $80 million annual savings from the Restructuring Program to ensure margin expansion continues.